Zhernakova, Yu V
| Issue | Section | Title | Abstract | File |
| Vol 7, No 1 (2010) | Articles | Znachenie agonista imidazolinovykh retseptorov moksonidina v lechenii bol'nykh arterial'noy gipertoniey i metabolicheskim sindromom. Rezul'taty issledovaniya MERSY v Rossii | Abstract | |
| Vol 8, No 2 (2011) | Articles | Svyaz' chisla komponentovmetabolicheskogo sindromas rasprostranennost'yui vyrazhennost'yu porazheniyaorganov-misheney | Abstract | |
| Vol 10, No 4 (2013) | Articles | The prevalence of arterial hypertension as a risk factor of cardiovascular diseases in one of the cities in Siberian Federal District | Abstract | |
| Vol 10, No 4 (2013) | Articles | Coagulogic risk factors of heart disease in the adult population of Tomsk | Abstract | |
| Vol 11, No 1 (2014) | Articles | Hypertension treatment features in perimenopausal women | Abstract |
 (Rus) |
| Vol 11, No 1 (2014) | Articles | Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components | Abstract |
(Rus) |
| Vol 11, No 2 (2014) | Articles | Recommendations on treatment strategies in hypertensivepatientswithmetabolic disorders | Abstract |
(Rus) |
| Vol 11, No 4 (2014) | Articles | The prevalence of carotid atherosclerosis in spontaneous populations in Tomsk | Abstract |
(Rus) |
| Vol 11, No 4 (2014) | Articles | The state of the vascular wall in adult population of Tomsk in the framework of the project ESSAY RF | Abstract |
(Rus) |
| Vol 12, No 2 (2015) | Articles | Calcium channel blockers: more than 50 years on guard of health | Abstract |
(Rus) |
| Vol 12, No 1 (2015) | Articles | The role of beta-blockers in the treatment of arterial hypertension: what do we know today | Abstract |
(Rus) |
| Vol 12, No 3 (2015) | Articles | Experts of RMSAH opinion: the fixed combination of azilsartan medoxomil and chlortalidone is broadening options of the combined therapyin patients with arterial hypertension | Abstract |
(Rus) |
| Vol 12, No 1 (2015) | Articles | Patients with arterial hypertension associated with metabolic disorders: characteristics and therapeutic approach | Abstract |
(Rus) |
| Vol 13, No 3 (2016) | Articles | The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan | Abstract |
(Rus) |
| Vol 13, No 3 (2016) | Articles | Control of cardiovascular risk in patients with diabetes | Abstract |
(Rus) |
| Vol 14, No 1 (2017) | Articles | Cardiovascular risk factors in people with high normal blood pressure in Russian population (based on data obtained in ESSE-RF epidemiological study) | Abstract |
(Rus) |
| Vol 13, No 4 (2016) | Articles | The patients of high cardiovascular risk of healthy: unrecognized metabolic syndrome | Abstract |
(Rus) |
| Vol 14, No 1 (2017) | Articles | Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients | Abstract |
(Rus) |
| Vol 14, No 3 (2017) | Articles | The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders | Abstract |
(Rus) |
| Vol 15, No 1 (2018) | Articles | The prevalence of diabetes mellitus in population of hypertensive patients according to ESSE RF study results | Abstract |
(Rus) |
| Vol 15, No 3 (2018) | Articles | Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines] | Abstract |
(Rus) |
| Vol 15, No 3 (2018) | Articles | Obesity as a predictor for cardiovascular disease development: role of localized fat depot | Abstract |
(Rus) |
| Vol 15, No 4 (2018) | Articles | Polypill" conception in modern cardiology | Abstract |
(Rus) |
| Vol 15, No 4 (2018) | Articles | Epicardial fat: a new cardiometabolic risk marker, a new therapeutic goal in obese patients | Abstract |
(Rus) |
| Vol 15, No 4 (2018) | Articles | Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity | Abstract |
(Rus) |
| Vol 6, No 4 (2009) | Articles | The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA) | Abstract | |
| Vol 8, No 1 (2011) | Articles | Tyazhest' metabolicheskogo sindroma opredelyaetsya chislom ego komponentov. | Abstract | |
| Vol 8, No 3 (2011) | Articles | Vliyanie chisla odnovremennovstrechayushchikhsya komponentovmetabolicheskogo sindroma na tyazhest'arterial'noy gipertonii,rasprostranennost' i vyrazhennost'porazheniya organov-misheneyu dannykh bol'nykh | Abstract | |
| Vol 8, No 4 (2011) | Articles | Vliyanie stepeni narusheniy uglevodnogo obmena na tyazhest' arterial'noy gipertonii, rasprostranennost' i vyrazhennost' porazheniya organov-misheney u bol'nykh s metabolicheskim sindromom | Abstract | |
| Vol 16, No 1 (2019) | Articles | Diagnosis and treatment of arterial hypertension [Guidelines] | Abstract |
(Rus) |